- Home
- IBTA vs TWST Comparison
IBTA vs TWST Comparison
Compare IBTA & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBTA
- TWST
- Stock Information
- Founded
- IBTA 2011
- TWST 2013
- Country
- IBTA United States
- TWST United States
- Employees
- IBTA N/A
- TWST N/A
- Industry
- IBTA
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IBTA
- TWST Health Care
- Exchange
- IBTA Nasdaq
- TWST Nasdaq
- Market Cap
- IBTA 2.2B
- TWST 2.3B
- IPO Year
- IBTA 2024
- TWST 2018
- Fundamental
- Price
- IBTA $47.69
- TWST $36.80
- Analyst Decision
- IBTA Buy
- TWST Buy
- Analyst Count
- IBTA 10
- TWST 10
- Target Price
- IBTA $72.30
- TWST $51.80
- AVG Volume (30 Days)
- IBTA 462.7K
- TWST 1.3M
- Earning Date
- IBTA 05-14-2025
- TWST 05-05-2025
- Dividend Yield
- IBTA N/A
- TWST N/A
- EPS Growth
- IBTA 80.28
- TWST N/A
- EPS
- IBTA 2.56
- TWST N/A
- Revenue
- IBTA $367,254,000.00
- TWST $330,189,000.00
- Revenue This Year
- IBTA $6.16
- TWST $22.54
- Revenue Next Year
- IBTA $15.64
- TWST $17.77
- P/E Ratio
- IBTA $18.63
- TWST N/A
- Revenue Growth
- IBTA 14.75
- TWST 25.85
- 52 Week Low
- IBTA $31.40
- TWST $27.41
- 52 Week High
- IBTA $110.95
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- IBTA N/A
- TWST 43.01
- Support Level
- IBTA N/A
- TWST $34.17
- Resistance Level
- IBTA N/A
- TWST $40.85
- Average True Range (ATR)
- IBTA 0.00
- TWST 3.61
- MACD
- IBTA 0.00
- TWST 0.10
- Stochastic Oscillator
- IBTA 0.00
- TWST 44.88
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.